Sort
64,565 grants matching “drug discovery”
Molecular Mechanism of Mammalian DNA Excision Repair and the Circadian Clock
$1,002,711Aziz Sancar · Univ Of North Carolina Chapel Hill · R35 · FY2024 · GM
Molecular Mechanism of Mammalian DNA Excision Repair and the Circadian Clock
$1,002,711Aziz Sancar · Univ Of North Carolina Chapel Hill · R35 · FY2022 · GM
Molecular Mechanism of Mammalian DNA Excision Repair and the Circadian Clock
$1,002,711Aziz Sancar · Univ Of North Carolina Chapel Hill · R35 · FY2021 · GM
Molecular Mechanism of Mammalian DNA Excision Repair and the Circadian Clock
$1,002,711Aziz Sancar · Univ Of North Carolina Chapel Hill · R35 · FY2023 · GM
Molecular Mechanism of Mammalian DNA Excision Repair and the Circadian Clock
$1,002,711Aziz Sancar · Univ Of North Carolina Chapel Hill · R35 · FY2025 · GM
Adaptable and scalable electroporation for cellular therapy
$1,002,657Harold G Craighead · Cytequest, Inc. · R44 · FY2024 · GM
Administrative Core
$1,002,447Michael S. Saag · University Of Alabama At Birmingham · P30 · FY2015 · AI
Non-Clinical Pharmacology of CX-01
$1,002,340Galina Vid · Ceramedix Holding, Llc · R44 · FY2024 · AI
Molecular Pathogenesis Of JC Virus & Progressive Multifocal Leukoencephalopathy
$1,002,118Eugene O. Major · National Institute Of Neurological Disorders And Stroke · ZIA · FY2012 · NS
Development of a small molecule activator of integrin cell adhesion to enhance therapeutic responses to checkpoint blockade in cancer
$1,001,898Upendra Marathi · 7 Hills Pharma, Llc · R42 · FY2019 · CA
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
$1,001,634Martin W Brechbiel · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA
Development of Hepatitis C Virus Inhibitors
$1,001,572Glen Andrew Coburn · Progenics Pharmaceuticals, Inc. · R44 · FY2006 · AI
Amish Connectome Project on Mental Illness
$1,001,333L. Elliot Hong · University Of Maryland Baltimore · U01 · FY2017 · MH
A Synchrotron Radiation Structural Biology Resource
$1,001,289Keith O Hodgson · Stanford University · P30 · FY2025 · GM
Cell-free assay technologies for the identification of active compounds
$1,001,166Barry Okeefe · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Discovering mechanisms of neuroblastoma tumorigenesis to improve patient outcomes
$1,001,040John M Maris · Children'S Hosp Of Philadelphia · R35 · FY2019 · CA
Small Molecule Inhibitors of HIV1 Nef Virulence Factor for Treatment of HIV_AIDS
$1,001,024Thomas Edward Smithgall · Fox Chase Chemical Diversity Center, Inc · R42 · FY2016 · GM
An all-optical electrophysiology platform for the discovery of pain therapeutics
$1,000,946Owen B. McManus · Q-State Biosciences, Inc. · R44 · FY2020 · NS
Optimization of small molecule SERCA2b activators to inhibit neuron loss in Alzheimer's disease
$1,000,655Russell Dahl · Neurodon Llc · R42 · FY2021 · AG
The Cancer Target Discovery and Development Network at UCSF
$1,000,618Michael T McManus · University Of California, San Francisco · U01 · FY2019 · CA
Building Opioid recovery support Networks to engage and retain young adults in Medication for Opioid Use Disorder (BOND)
$1,000,593Lisa A Marsch · Dartmouth College · UG1 · FY2023 · DA
Kidney Microphysiological Analysis Platforms (MAP) to Optimize Function and Model Disease
$1,000,484Joseph Vincent Bonventre · Brigham And Women'S Hospital · UG3 · FY2017 · TR
Nanodiamond Quantum Sensors for Free Radical Detection
$1,000,263Marco Torelli · Adamas Nanotechnologies, Inc. · R44 · FY2025 · TR
Discovery and Validation of a Novel Response Biomarker Signature for Painful Peripheral Neuropathy
$1,000,168Mikhail I. Nemenov · Lasmed, Llc · R61 · FY2022 · NS
From Academia to Business: Development of Novel Therapeutics Against HPV-Associated Cancer
$1,000,028Anne Rietz · Kovina Therapeutics Inc. · R44 · FY2024 · CA